Your browser doesn't support javascript.
loading
Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection.
Rosli, Sarah; Kirby, Francis J; Lawlor, Kate E; Rainczuk, Kate; Drummond, Grant R; Mansell, Ashley; Tate, Michelle D.
Afiliación
  • Rosli S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Kirby FJ; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
  • Lawlor KE; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Rainczuk K; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
  • Drummond GR; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Mansell A; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.
  • Tate MD; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Br J Pharmacol ; 176(19): 3834-3844, 2019 10.
Article en En | MEDLINE | ID: mdl-31271646

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tiazoles / Probenecid / Infecciones por Orthomyxoviridae / Receptores Purinérgicos P2X7 / Proteína con Dominio Pirina 3 de la Familia NLR / Inflamación Límite: Animals Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tiazoles / Probenecid / Infecciones por Orthomyxoviridae / Receptores Purinérgicos P2X7 / Proteína con Dominio Pirina 3 de la Familia NLR / Inflamación Límite: Animals Idioma: En Revista: Br J Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Australia